Large cohorts of patients with a diagnosis of idiopathic pulmonary fibrosis (IPF) have reported ANCA-positive prevalence rates ranging from 9.8 to 17%, mostly anti-MPO antibodies, and especially in the setting of associated AAV [5,6,7]. This evidence concerns the gene MPO and pulmonary fibrosis.